Pharmacokinetics and safety of TCMCB07, a melanocortin-4 antagonist peptide in dogs.

Pharmacol Res Perspect · 2021 · PMC8135083 · PMID 34014033

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

approached significancep ≤ .054so close (0.05 < p ≤ 0.1)

While the effect of dose approached significance ( p ≤ .054), there was a significant overall effect of time on drug ( p ≤ .001) and a significant interaction between dose and time ( p ≤ .001) indicating that the higher dose produced a greater response in body weight.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.